3Fitchen JJ, Cline MJ, Saxon A, et al. Serum inhibitors ofhematopoiesis in a patient with aplastie anemia and systemic: lu- pus erythematosus. Recovery after exchange plasmapheresis. Am J Med, 1979, 66: 537-542.
4Abdou NI, Lindsley HB, Pollock A, et al. Plasmapheresis in ac- tive systemic lupus erythematosus: effects on clinical, serum,and cellular abnormalities. Case report. Clin Immunol hn- munopathol, 1981, 19: 44-54.
5Walport M J, Hubbard WN, Hughes GR. Reversal of aplasticanaemia secondary to systemic lupus erythematosus by high-dose intravenous cyclophosphamide. Br Med J (Clin Res Ed), 1982, 285 : 769-770.
6Stricker RB, Shuman MA. Aplastic anemia complicating systemic lupus erythemat0sus: response to androgens in two patients. Am J Hematol, 1984, 17: 193-201.
7Brooks B J, Broxmeyer HE, Bryan CF, et al. Serum inhibitor in systemic lupus erythematosus associated with aplastic anemia. Arch Intern Med, 1984, 144: 1474-1477.
8Winkler A, Jackson RW, Kay DS, et al. High-dose intravenous cyclophosphamide treatment of systemic lupus erythematosus-as- sociated aplastic anemia. Arthritis Rheum, 1988, 31 : 693-694.
9Bailey FA, Lilly M, Bertoli LF, et al. An antibody that inhibits in vitro bone marrow proliferation in a patient with systemic lupus erythematosus and aplastic anemia. Arthritis Rheum, 1989, 32: 901-905.
10Hinterberger-Fischer M, Hocker P, Lechner K, et al. Oral cy- closporin-A is effective treatment for untreated and also for previ-ously immunosuppressed patients with severe bone marrow failure. Eur J Haematol, 1989, 43: 136-142.
